Brief: Tarsus Announces Pricing Of $100 Mln Public Offering
01/03/2024 05:08
March 1 (Reuters) - Tarsus Pharmaceuticals Inc TARS.O :
* TARSUS ANNOUNCES PRICING OF $100.0 MILLION PUBLIC OFFERING
* TARSUS PHARMACEUTICALS INC - PRICING OF AN UNDERWRITTEN
PUBLIC
OFFERING OF 2.8 MILLION SHARES OF ITS COMMON STOCK AT A PRICE OF
$32.00 PER SHARE
Source text for Eikon: ID:nGNX7jgRpr
Further company coverage: TARS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tarsus Pharmaceuticals
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Tarsus Pharmaceuticals Files For Offering Of Up To 2.91 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
Tarsus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition (updated)